Cargando…
Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS
OBJECTIVE: Several factors influence the clinical course of autoimmune inflammatory diseases such as MS and inflammatory bowel disease. Only recently, the complex interaction between the gut microbiome, dietary factors, and metabolism has started to be appreciated with regard to its potential to mod...
Autores principales: | Rothhammer, Veit, Borucki, Davis M., Garcia Sanchez, Maria Isabel, Mazzola, Maria Antonietta, Hemond, Christopher C., Regev, Keren, Paul, Anu, Kivisäkk, Pia, Bakshi, Rohit, Izquierdo, Guillermo, Weiner, Howard L., Quintana, Francisco J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473958/ https://www.ncbi.nlm.nih.gov/pubmed/28642887 http://dx.doi.org/10.1212/NXI.0000000000000359 |
Ejemplares similares
-
Detection of aryl hydrocarbon receptor agonists in human samples
por: Rothhammer, Veit, et al.
Publicado: (2018) -
Aryl Hydrocarbon Receptor Plasma Agonist Activity Correlates With
Disease Activity in Progressive MS
por: Tsaktanis, Thanos, et al.
Publicado: (2020) -
Serum antibodies to phosphatidylcholine in MS
por: Sádaba, Maria Cruz, et al.
Publicado: (2020) -
Aryl Hydrocarbon Receptor Activation in Astrocytes by Laquinimod Ameliorates Autoimmune Inflammation in the CNS
por: Rothhammer, Veit, et al.
Publicado: (2021) -
MRI phenotypes in MS: Longitudinal changes and miRNA signatures
por: Hemond, Christopher C., et al.
Publicado: (2019)